IgA2+ B cells and IgA2 anti-dsDNA antibodies are selectively targeted by belimumab after rituximab therapy in systemic lupus erythematosus.
已完结
10
由 000 发布于 2025/7/31 23:35:25
DOI:10.1016/j.xcrm.2025.102247
作者：Daniel McCluskey,?Muhammad R A Shipa,?Kashfia Chowdhury,?Judith A James,?Laura A Cooney,?Michael R Ehrenstein
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1016/j.xcrm.2025.102247
作者：Daniel McCluskey,?Muhammad R A Shipa,?Kashfia Chowdhury,?Judith A James,?Laura A Cooney,?Michael R Ehrenstein
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1016/j.xcrm.2025.102247
Elsevier
其它数据库
京公网安备 11010802042870号
